# B&G Foods, Inc.: financial statements, quarterly

BGS · NYSE · CIK 1278027 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/bgs.md) · [Financials](/companies/bgs/financials.md) · [Filings](/companies/bgs/filings.md) · [Insiders](/companies/bgs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bgs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [503](/filings/0001558370-24-014430.md) | [578 d](/filings/0001104659-26-022961.md) | [475](/filings/0001558370-25-006621.md) | [445](/filings/0001558370-25-010103.md) | [461](/filings/0001104659-25-106992.md) | [552 d](/filings/0001104659-26-022961.md) | [425](/filings/0001104659-26-060227.md) | [424](/filings/0001104659-26-094525.md) | [439](/filings/0001104659-25-106992.md) | [540 d](/filings/0001104659-26-022961.md) | [409](/filings/0001104659-26-060227.md) | [383](/filings/0001104659-26-094525.md) |
| Cost of revenue | $m | [389](/filings/0001558370-24-014430.md) | [453 d](/filings/0001104659-26-022961.md) | [366](/filings/0001558370-25-006621.md) | [353](/filings/0001558370-25-010103.md) | [359](/filings/0001104659-25-106992.md) | [433 d](/filings/0001104659-26-022961.md) | [335](/filings/0001104659-26-060227.md) | [337](/filings/0001104659-26-094525.md) | [340](/filings/0001104659-25-106992.md) | [417 d](/filings/0001104659-26-022961.md) | [329](/filings/0001104659-26-060227.md) | [304](/filings/0001104659-26-094525.md) |
| Gross profit | $m | [114](/filings/0001558370-24-014430.md) | [125 d](/filings/0001104659-26-022961.md) | [109](/filings/0001558370-25-006621.md) | [92.0](/filings/0001558370-25-010103.md) | [102](/filings/0001104659-25-106992.md) | [119 d](/filings/0001104659-26-022961.md) | [90.1](/filings/0001104659-26-060227.md) | [87.0](/filings/0001104659-26-094525.md) | [99.0](/filings/0001104659-25-106992.md) | [123 d](/filings/0001104659-26-022961.md) | [79.9](/filings/0001104659-26-060227.md) | [79.6](/filings/0001104659-26-094525.md) |
| Selling, general and administrative | $m | [48.2](/filings/0001558370-24-014430.md) | [53.2 d](/filings/0001104659-26-022961.md) | [48.6](/filings/0001558370-25-006621.md) | [43.1](/filings/0001558370-25-010103.md) | [46.0](/filings/0001104659-25-106992.md) | [50.3 d](/filings/0001104659-26-022961.md) | [49.1](/filings/0001104659-26-060227.md) | [47.2](/filings/0001104659-26-094525.md) | [44.6](/filings/0001104659-25-106992.md) | [54.0 d](/filings/0001104659-26-022961.md) | [50.2](/filings/0001104659-26-060227.md) | [40.6](/filings/0001104659-26-094525.md) |
| Operating income | $m | [(72.5)](/filings/0001558370-24-014430.md) | [41.6 d](/filings/0001104659-26-022961.md) | [(15.6)](/filings/0001558370-25-006621.md) | [43.8](/filings/0001558370-25-010103.md) | [51.2](/filings/0001104659-25-106992.md) | [(257) d](/filings/0001104659-26-022961.md) | [35.8](/filings/0001104659-26-060227.md) | [22.0](/filings/0001104659-26-094525.md) | [11.0](/filings/0001104659-25-106992.md) | [28.2 d](/filings/0001104659-26-022961.md) | [(11.0)](/filings/0001104659-26-060227.md) | [34.6](/filings/0001104659-26-094525.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(24.7)](/filings/0001558370-24-014430.md) | [(0.3) d](/filings/0001104659-26-022961.md) | [(12.1)](/filings/0001558370-25-006621.md) | [3.1](/filings/0001558370-25-010103.md) | [2.7](/filings/0001104659-25-106992.md) | [(72.9) d](/filings/0001104659-26-022961.md) | [(1.6)](/filings/0001104659-26-060227.md) | [(2.8)](/filings/0001104659-26-094525.md) | [(5.9)](/filings/0001104659-25-106992.md) | [5.8 d](/filings/0001104659-26-022961.md) | [(12.7)](/filings/0001104659-26-060227.md) | [1.6](/filings/0001104659-26-094525.md) |
| Net income | $m | [(82.7)](/filings/0001558370-24-014430.md) | [2.6 d](/filings/0001104659-26-022961.md) | [(40.2)](/filings/0001104659-25-106992.md) | [3.9](/filings/0001104659-25-106992.md) | [7.5](/filings/0001104659-25-106992.md) | [(222) d](/filings/0001104659-26-022961.md) | [0.8](/filings/0001104659-26-094525.md) | [(9.8)](/filings/0001104659-26-094525.md) | [(19.1)](/filings/0001104659-25-106992.md) | [(15.2) d](/filings/0001104659-26-022961.md) | [(32.5)](/filings/0001104659-26-094525.md) | [(4.0)](/filings/0001104659-26-094525.md) |
| Diluted EPS | $ per share | [(1.11)](/filings/0001558370-24-014430.md) | not reported | [(0.51)](/filings/0001558370-25-006621.md) | [0.05](/filings/0001558370-25-010103.md) | [0.09](/filings/0001104659-25-106992.md) | not reported | [0.01](/filings/0001104659-26-060227.md) | [(0.12)](/filings/0001104659-26-094525.md) | [(0.24)](/filings/0001104659-25-106992.md) | not reported | [(0.41)](/filings/0001104659-26-060227.md) | [(0.05)](/filings/0001104659-26-094525.md) |
| Basic EPS | $ per share | [(1.11)](/filings/0001558370-24-014430.md) | not reported | [(0.51)](/filings/0001558370-25-006621.md) | [0.05](/filings/0001558370-25-010103.md) | [0.09](/filings/0001104659-25-106992.md) | not reported | [0.01](/filings/0001104659-26-060227.md) | [(0.12)](/filings/0001104659-26-094525.md) | [(0.24)](/filings/0001104659-25-106992.md) | not reported | [(0.41)](/filings/0001104659-26-060227.md) | [(0.05)](/filings/0001104659-26-094525.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [360](/filings/0001558370-23-018441.md) | [41.1](/filings/0001558370-25-001513.md) | [42.5](/filings/0001558370-24-007339.md) | [40.3](/filings/0001558370-24-011087.md) | [54.7](/filings/0001558370-24-014430.md) | [50.6](/filings/0001104659-26-022961.md) | [61.2](/filings/0001558370-25-006621.md) | [54.1](/filings/0001558370-25-010103.md) | [60.9](/filings/0001104659-25-106992.md) | [56.3](/filings/0001104659-26-094525.md) | [64.5](/filings/0001104659-26-060227.md) | [592](/filings/0001104659-26-094525.md) |
| Current assets | $m | [1,281](/filings/0001558370-23-018441.md) | [803](/filings/0001558370-25-001513.md) | [785](/filings/0001558370-24-007339.md) | [797](/filings/0001558370-24-011087.md) | [883](/filings/0001558370-24-014430.md) | [781](/filings/0001104659-26-022961.md) | [758](/filings/0001558370-25-006621.md) | [763](/filings/0001558370-25-010103.md) | [817](/filings/0001104659-25-106992.md) | [740](/filings/0001104659-26-094525.md) | [674](/filings/0001104659-26-060227.md) | [1,207](/filings/0001104659-26-094525.md) |
| Total assets | $m | [3,957](/filings/0001558370-23-018441.md) | [3,463](/filings/0001558370-25-001513.md) | [3,361](/filings/0001558370-24-007339.md) | [3,352](/filings/0001558370-24-011087.md) | [3,418](/filings/0001558370-24-014430.md) | [2,994](/filings/0001104659-26-022961.md) | [2,954](/filings/0001558370-25-006621.md) | [2,937](/filings/0001558370-25-010103.md) | [2,943](/filings/0001104659-25-106992.md) | [2,835](/filings/0001104659-26-094525.md) | [2,836](/filings/0001104659-26-060227.md) | [3,360](/filings/0001104659-26-094525.md) |
| Current liabilities | $m | [843](/filings/0001558370-23-018441.md) | [262](/filings/0001558370-25-001513.md) | [244](/filings/0001558370-24-007339.md) | [490](/filings/0001558370-24-011087.md) | [538](/filings/0001558370-24-014430.md) | [237](/filings/0001104659-26-022961.md) | [229](/filings/0001558370-25-006621.md) | [260](/filings/0001558370-25-010103.md) | [255](/filings/0001104659-25-106992.md) | [223](/filings/0001104659-26-094525.md) | [225](/filings/0001104659-26-060227.md) | [747](/filings/0001104659-26-094525.md) |
| Total liabilities | $m | [3,116](/filings/0001558370-23-018441.md) | [2,628](/filings/0001558370-25-001513.md) | [2,579](/filings/0001558370-24-007339.md) | [2,587](/filings/0001558370-24-011087.md) | [2,663](/filings/0001558370-24-014430.md) | [2,469](/filings/0001104659-26-022961.md) | [2,441](/filings/0001558370-25-006621.md) | [2,436](/filings/0001558370-25-010103.md) | [2,472](/filings/0001104659-25-106992.md) | [2,382](/filings/0001104659-26-094525.md) | [2,433](/filings/0001104659-26-060227.md) | [2,965](/filings/0001104659-26-094525.md) |
| Long-term debt | $m | [1,929](/filings/0001558370-23-018441.md) | [2,023](/filings/0001558370-25-001513.md) | [2,014](/filings/0001558370-24-007339.md) | [1,779](/filings/0001558370-24-011087.md) | [1,814](/filings/0001558370-24-014430.md) | [2,015](/filings/0001104659-26-022961.md) | [2,000](/filings/0001558370-25-006621.md) | [1,985](/filings/0001558370-25-010103.md) | [2,020](/filings/0001104659-25-106992.md) | [1,946](/filings/0001104659-26-094525.md) | [2,001](/filings/0001104659-26-060227.md) | [2,008](/filings/0001104659-26-094525.md) |
| Current portion of debt | $m | [555](/filings/0001558370-23-018441.md) | [22.0](/filings/0001558370-25-001513.md) | [22.0](/filings/0001558370-24-007339.md) | [265](/filings/0001558370-24-011087.md) | [265](/filings/0001558370-24-014430.md) | [5.6](/filings/0001104659-26-022961.md) | [5.6](/filings/0001558370-25-006621.md) | [5.6](/filings/0001558370-25-010103.md) | [5.6](/filings/0001104659-25-106992.md) | [4.5](/filings/0001104659-26-094525.md) | [4.5](/filings/0001104659-26-060227.md) | [514](/filings/0001104659-26-094525.md) |
| Shareholders' equity | $m | [841](/filings/0001558370-24-014430.md) | [835](/filings/0001104659-26-022961.md) | [781](/filings/0001104659-25-106992.md) | [765](/filings/0001104659-25-106992.md) | [755](/filings/0001104659-25-106992.md) | [525](/filings/0001104659-26-094525.md) | [513](/filings/0001104659-26-094525.md) | [501](/filings/0001104659-26-094525.md) | [471](/filings/0001104659-25-106992.md) | [453](/filings/0001104659-26-094525.md) | [403](/filings/0001104659-26-094525.md) | [395](/filings/0001104659-26-094525.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.3 d](/filings/0001558370-24-014430.md) | [92.1 d](/filings/0001104659-26-022961.md) | [35.1](/filings/0001558370-25-006621.md) | [11.3 d](/filings/0001558370-25-010103.md) | [4.2 d](/filings/0001104659-25-106992.md) | [80.3 d](/filings/0001104659-26-022961.md) | [52.7](/filings/0001104659-26-060227.md) | [17.8 d](/filings/0001104659-26-094525.md) | [(64.6) d](/filings/0001104659-25-106992.md) | [95.4 d](/filings/0001104659-26-022961.md) | [23.6](/filings/0001104659-26-060227.md) | [34.4 d](/filings/0001104659-26-094525.md) |
| Capital expenditure | $m | [6.3 d](/filings/0001558370-24-014430.md) | [8.7 d](/filings/0001104659-26-022961.md) | [7.6](/filings/0001558370-25-006621.md) | [6.1 d](/filings/0001558370-25-010103.md) | [4.8 d](/filings/0001104659-25-106992.md) | [8.7 d](/filings/0001104659-26-022961.md) | [10.4](/filings/0001104659-26-060227.md) | [6.4 d](/filings/0001104659-26-094525.md) | [6.1 d](/filings/0001104659-25-106992.md) | [7.8 d](/filings/0001104659-26-022961.md) | [4.9](/filings/0001104659-26-060227.md) | [6.2 d](/filings/0001104659-26-094525.md) |
| Dividends paid | $m | [13.7 d](/filings/0001558370-24-014430.md) | [14.9 d](/filings/0001104659-26-022961.md) | [14.9](/filings/0001558370-25-006621.md) | [15.0 d](/filings/0001558370-25-010103.md) | [15.0 d](/filings/0001104659-25-106992.md) | [15.0 d](/filings/0001104659-26-022961.md) | [15.0](/filings/0001104659-26-060227.md) | [15.2 d](/filings/0001104659-26-094525.md) | [15.2 d](/filings/0001104659-25-106992.md) | [15.2 d](/filings/0001104659-26-022961.md) | [15.2](/filings/0001104659-26-060227.md) | [15.4 d](/filings/0001104659-26-094525.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.0](/filings/0001558370-23-018441.md) | [71.8](/filings/0001558370-24-007339.md) | [72.4](/filings/0001558370-24-011087.md) | [74.4](/filings/0001558370-24-014430.md) | [78.6](/filings/0001558370-25-006621.md) | [79.4](/filings/0001558370-25-010103.md) | [79.4](/filings/0001104659-25-106992.md) | [79.7](/filings/0001104659-26-060227.md) | [79.9](/filings/0001104659-26-094525.md) | [80.0](/filings/0001104659-25-106992.md) | [80.2](/filings/0001104659-26-060227.md) | [81.2](/filings/0001104659-26-094525.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 81,275,671 at 2026-08-06, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-094525.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.